Adrenal Cushing's syndrome
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
120
|
9
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Endotoxemia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
401
|
5
|
0.200 |
None |
1.000 |
1 |
|
2010 |
2010 |
Alcohol or Other Drugs use
|
disease |
|
Mental or Behavioral Dysfunction
|
108
|
21
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Central neuroblastoma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
2419
|
231
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Cannabis use
|
disease |
|
Mental or Behavioral Dysfunction
|
74
|
44
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Nonalcoholic Steatohepatitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
434
|
17
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
cocaine use
|
disease |
|
Mental or Behavioral Dysfunction
|
67
|
8
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Childhood Neuroblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2420
|
231
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Stage 0 Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Stage IIA Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Stage IIB Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Stage III Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Stage IV Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Attention deficit hyperactivity disorder, combined type
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Alcoholic Steatohepatitis
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
30
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Venous Thromboembolism
|
phenotype |
Cardiovascular Diseases
|
Disease or Syndrome
|
378
|
408
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Major Depressive Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1236
|
1451
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Awakening Epilepsy
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
83
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Learning Disabilities
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders
|
Mental or Behavioral Dysfunction
|
103
|
5
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Stress induced hyperglycaemia
|
disease |
|
Disease or Syndrome
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Sleeplessness
|
phenotype |
Nervous System Diseases; Mental Disorders
|
Sign or Symptom
|
174
|
30
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Ischemic stroke
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
1159
|
704
|
0.010 |
None |
< 0.001 |
1 |
|
2013 |
2013 |
Cardiac Hypertrophy
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
88
|
11
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Cirrhosis
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
919
|
110
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Acth-Independent Macronodular Adrenal Hyperplasia
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
46
|
8
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |